Skip to main content
OpenTrials
Completed

NCT Number: NCT05794607

Investigation of the Effectiveness of Tele-pulmonary Rehabilitation After Lung Resection

As a result of the review in the literature, no study was found in which tele-pulmonary rehabilitation was applied after physiotherapist-supervised lung resection via video conferencing.

Therefore, in this study, it was planned to investigate the effectiveness of tele-pulmonary rehabilitation in patients diagnosed with lung cancer and undergoing lung resection.

Completed

Looking for future studies?

Notify Me

Key information

Age range

55 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kartal Dr Lutfi Kırdar City Hospital

Istanbul, 34000, Turkey (Türkiye)

About this study

Research; It was planned as a prospective and randomized controlled study. The research universe is Istanbul Kartal Dr. Lütfi Kırdar City Hospital Chest Surgery Clinic will consist of cases with a preliminary diagnosis of lung cancer. The sample of the study, on the other hand, will consist of patients who agreed to participate in the study and who met the inclusion criteria, who were planned for lung resection.

  • Study group (n=18); The treatment features of the tele-pulmonary rehabilitation group via videoconferencing are; Within the scope of the tele-pulmonary rehabilitation program, an exercise program consisting of lower-upper extremity strengthening training and flexibility training, breathing exercises training (diaphragmatic breathing, thoracic expansion exercises and forced expiration) and aerobic exercise training will be created before discharge, exercise session will be followed. Re-evaluation will be done after 8 weeks.Exercise intensity will be planned as 2 days a week with supervision and 1 day without supervision, 3 days a week in total. Exercise safety will be ensured by taking the severity of shortness of breath of the patients as a reference.
  • Control group (n=18); Patients in the tele-pulmonary rehabilitation control group will be given respiratory and aerobic exercise advice before discharge. Re-evaluation will be done after 8 weeks.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male and female patients aged 55-75 years diagnosed with lung cancer
  • Patients who underwent lobectomy, segmentectomy, bilobectomy, and pneumonectomy by either VATS or thoracotomy surgeries
  • Patients who can use phones and make video calls

Exclusion criteria

  • Patients with heart failure or atrial fibrillation
  • Patients with acute infection at the time of assessment
  • Patients who have had myocardial infarction in the last six months
  • Patients with any comorbidities such as uncontrolled diabetes mellitus and/or hypertension
  • Patients with any problem that would limit physical activity

Treatment and study plan

Rehabilitation group

Other

The intervention group will be given strength training to improve muscle strength and flexibility, and aerobic exercise training to improve exercise capacity with function.

Primary outcomes

  1. Functional exercises capacity

    Time frame: 8 weeks

    A 6-minute walk test will be performed to determine functional exercise capacity.

  2. Pulmonary function test

    Time frame: 8 weeks

    Pulmonary function test will be made in accordance with ats criteria

  3. Peripheral muscle strength

    Time frame: 8 weeks

    Peripheral muscle strength will be done with 'Lafayette' device

Secondary outcomes

  1. Anxiety and depression

    Time frame: 8 weeks

    Hospital anxiety and depression scale (HAD scale); It will be used to measure and evaluate patients' anxiety and depression scales.

  2. Determination of quality of life

    Time frame: 8 weeks

    EORTC QLQ-C30; This scale is a widely used quality of life scale in cancer patients all over the world.

  3. Cognitive functions

    Time frame: 8 weeks

    Mini mental state test; will be used to evaluate postoperative cognitive dysfunction.

Sponsors and collaborators

Lead sponsor

Halime Sinem Barutçu

Other Gov

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2026
First posted
Apr 3, 2023
Registry last updated
Mar 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.